169 related articles for article (PubMed ID: 28302509)
21. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
[TBL] [Abstract][Full Text] [Related]
22. Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold.
Adamska-Bartłomiejczyk A; De Marco R; Gentilucci L; Kluczyk A; Janecka A
Bioorg Med Chem; 2017 Apr; 25(8):2399-2405. PubMed ID: 28318893
[TBL] [Abstract][Full Text] [Related]
23. 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.
Weltrowska G; Lemieux C; Chung NN; Guo JJ; Wilkes BC; Schiller PW
Bioorg Med Chem; 2014 Sep; 22(17):4581-6. PubMed ID: 25129170
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes.
Pelotte AL; Smith RM; Ayestas M; Dersch CM; Bilsky EJ; Rothman RB; Deveau AM
Bioorg Med Chem Lett; 2009 May; 19(10):2811-4. PubMed ID: 19364645
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the interaction between the atypical agonist c[YpwFG] and MOR.
Gentilucci L; Squassabia F; De Marco R; Artali R; Cardillo G; Tolomelli A; Spampinato S; Bedini A
FEBS J; 2008 May; 275(9):2315-37. PubMed ID: 18397320
[TBL] [Abstract][Full Text] [Related]
26. Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking.
Sagara T; Egashira H; Okamura M; Fujii I; Shimohigashi Y; Kanematsu K
Bioorg Med Chem; 1996 Dec; 4(12):2151-66. PubMed ID: 9022978
[TBL] [Abstract][Full Text] [Related]
27. [Binding characteristics of new synthesized opioid receptor ligands to cloned mu opioid receptors stably expressed in CHO cell].
Hu P; Ye CY; Qiu ZB; Yang HF; Zhang DC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):79-82. PubMed ID: 12905615
[TBL] [Abstract][Full Text] [Related]
28. Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation.
Xu GG; Zolotarskaya OY; Williams DA; Yuan Y; Selley DE; Dewey WL; Akbarali HI; Yang H; Zhang Y
ACS Med Chem Lett; 2017 Jan; 8(1):78-83. PubMed ID: 28105279
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm.
Pan L; Xu J; Yu R; Xu MM; Pan YX; Pasternak GW
Neuroscience; 2005; 133(1):209-20. PubMed ID: 15893644
[TBL] [Abstract][Full Text] [Related]
30. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
[TBL] [Abstract][Full Text] [Related]
31. Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.
Bartuzi D; Kaczor AA; Matosiuk D
J Chem Inf Model; 2015 Nov; 55(11):2421-34. PubMed ID: 26517559
[TBL] [Abstract][Full Text] [Related]
32. Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.
Marmolejo-Valencia AF; Martínez-Mayorga K
J Comput Aided Mol Des; 2017 May; 31(5):467-482. PubMed ID: 28364251
[TBL] [Abstract][Full Text] [Related]
33. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
34. Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
Deekonda S; Rankin D; Davis P; Lai J; Vanderah TW; Porecca F; Hruby VJ
Bioorg Med Chem; 2016 Jan; 24(2):85-91. PubMed ID: 26712115
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
[TBL] [Abstract][Full Text] [Related]
36. Cyclic mu-opioid receptor ligands containing multiple N-methylated amino acid residues.
Adamska-Bartłomiejczyk A; Janecka A; Szabó MR; Cerlesi MC; Calo G; Kluczyk A; Tömböly C; Borics A
Bioorg Med Chem Lett; 2017 Apr; 27(8):1644-1648. PubMed ID: 28318942
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists.
Pagare PP; Li M; Zheng Y; Kulkarni AS; Obeng S; Huang B; Ruiz C; Gillespie JC; Mendez RE; Stevens DL; Poklis JL; Halquist MS; Dewey WL; Selley DE; Zhang Y
J Med Chem; 2022 Mar; 65(6):5095-5112. PubMed ID: 35255685
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and functional expression of a mu-opioid receptor from rat brain.
Chen Y; Mestek A; Liu J; Hurley JA; Yu L
Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525
[TBL] [Abstract][Full Text] [Related]
39. Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor.
Ma H; Wang H; Gillespie JC; Mendez RE; Selley DE; Zhang Y
Bioorg Med Chem Lett; 2021 Jun; 41():127953. PubMed ID: 33766769
[TBL] [Abstract][Full Text] [Related]
40. Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors.
Huang B; Gunta R; Wang H; Li M; Cao D; Mendez RE; Gillespie JC; Chen C; Huang LM; Liu-Chen LY; Selley DE; Zhang Y
Bioorg Chem; 2021 Apr; 109():104702. PubMed ID: 33631465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
